Swarnava Chaudhuri
Post-doc, Tsinghua University, 2014-present;
Post-doc, Meharry Medical College, 2013-2014;
Post-doc, University of California, Santa Barbara, 2011-2012;
Ph.D, Microbiology & Immunology, University of Illinois at Chicago, 2011;
M.Sc, Biochemistry, University of Calcutta, 2005;
B.Sc, Microbiology, University of Calcutta, 2003;
Hobbies: Travelling, photography, reading
Email: swarnavachau{at}yahoo.com (Please replace {at} to @ in the address.)
The prolonged antibiotic regime during treatment of tuberculosis is a serious healthcare burden. The long treatment period for tuberculosis results from rifampicin tolerance in Mycobacteria. Reduced translational fidelity, which results in the formation of mistranslated protein variants, is a key mechanism behind rifampicin tolerance in mycobacteria. My project is to identify drugs that increase the translational fidelity in mycobacteria, and thereby make the bacterium more susceptible to rifampicin。The other part of my project is to identify the mechanism by which these drugs increase translational fidelity in mycobacteria.